Frankincense.jpg.webp

BosNext is a water-dispersible and highly concentrated Boswellia extract standardised to >40% Acetyl keto- β-Boswellic acid (AKBA). It is a highly absorbable formulation produced using patent-pending and clinically validated             technology.

Natural, water dispersible and highly concentrated Boswellia extract

Standardized to > 40% Acetyl keto- β-Boswellic acid (AKBA)

BosNext comprehensively resolves all the limitations of existing standard boswellia extracts such as lower concentration of AKBA (1 to 3%), non-dispersible, poor bioavailability, intense resinous smell (not suitable for food and beverage formats), limited applications (suitable only for capsule and tablets) and high levels of contaminants (residual solvents, heavy metals, aflatoxins and pesticides).

HIGHER CONCENTRATION OF AKBA 
 

BosNext is standardized to >40% ethanol extracted AKBA in bioavailable form, which is 13 times higher than the marketed standard boswellia extracts.
 

Acetyl keto- β-Boswellic acid (AKBA) is one of the main bioactive compound present in Boswellia gum resin and is the most potent inhibitor of 5-lipoxygenase, an enzyme responsible for inflammation. Despite the diverse bioactivity, low concentration and low bioavailability of AKBA still presents a formidable challenge to realizing its full potential as a health supplement. The marketed standard boswellia extracts generally contain 1 to 3% of AKBA, besides being poorly bioavailable, requiring high & multiple doses per day. Also the harsh solvents used in the extraction of boswellic acids makes it unsafe for long term human consumption.

WATER DISPERSIBLE 

BosNext is an emulsifier/surfactant free formulation which is completely dispersible in water.

Its water dispersibility will ensure higher absorption by increasing the surface area of otherwise clustered AKBA molecules; this enhances the interaction with water and thereby epithelial cells. It is developed on scientifically validated Self-D technology, which is validated for its bio-enhancing property and for enhancing the efficacy of phytochemicals without the addition of synthetic emulsifiers through human clinical studies.

bosnext.jpg

STANDARD EXTRACT

BIOAVAILABILITY MECHANISM…

Picture1.png

BosNext is completely water dispersible which will ensure higher absorption by increasing the surface area of otherwise clustered AKBA molecules; this enhances the interaction with water and thereby epithelial cells.

 

It is developed on scientifically validated Self-D technology, which is validated for its bio-enhancing property and for enhancing the efficacy of phytochemicals  

100 PERCENT NATURAL

BosNext is 100% natural, which makes it suitable for formulations and applications where customers do not want to add synthetic ingredients or excipients.

  • No Synthetic excipients

  • Solvent-free process

  • Ease-of-applicability in various formulations

PALATABLE ORGANOLEPTIC PROPERTIES

Bosnext has neutral taste and neutral odor compared to the standard extract which has a typical boswellia resinous taste and smell.

APPLICATION IN FUNCTIONAL FOODS

BosNext’s water dispersibility, neutral taste and neutral smell, makes it possible to formulate it into functional foods, including functional beverage products.

 

Dosage forms:

BosNext is palate-friendly due to its neutral taste and smell requiring no flavoring nor masking. Hence, it is suitable for a variety of formulations, both traditional and novel food and beverage formats alike. This includes, but not limited to, dosage forms of Capsules, tablets, RTDs (Ready-to-Drink formulations), chocolates, gummies, etc.

PRODUCT HIGHLIGHTS

  1. Standardized to >40% Acetyl keto- β-Boswellic acid (AKBA)

  2. Water Dispersible formula for enhanced bioavailability

  3. Palate friendly: Neutral taste & Neutral smell

  4. Supports Joint health and respiratory health

  5. Smaller dose: 100 mg once daily (500 mg for generic Boswellia product)

  6. 100% natural

ABOUT                     TECHNOLOGY

Self-D is Olene’s patent pending self-dispersing platform technology for creating bioavailable nutraceuticals. This is a disruptive innovation which makes it possible for nutraceuticals to be used in multifold applications and delivery forms. It is validated through a human clinical study for enhancing bioavailability of phytochemicals and human clinical efficacy studies for enhancing the bio-efficacy.